Health and Fitness Health and Fitness
Mon, January 12, 2009
Sun, January 11, 2009
Fri, January 9, 2009
Thu, January 8, 2009
Wed, January 7, 2009
Tue, January 6, 2009
Mon, January 5, 2009
[ Mon, Jan 05th 2009 ] - Market Wire
Avexa and Progen Merger Update
Fri, January 2, 2009
Thu, January 1, 2009
Wed, December 31, 2008
[ Wed, Dec 31st 2008 ] - Market Wire
Obesity Comes With a Price Tag
Tue, December 30, 2008
Mon, December 29, 2008
Wed, December 24, 2008
Tue, December 23, 2008
Mon, December 22, 2008
Sun, December 21, 2008
Fri, December 19, 2008
Thu, December 18, 2008

Northfield Laboratories Inc. Announces Second Quarter 2009 Financial Results Webcast


//health-fitness.news-articles.net/content/2009/ .. cond-quarter-2009-financial-results-webcast.html
Published in Health and Fitness on Monday, January 5th 2009 at 14:10 GMT, Last Modified on 2009-01-05 14:10:49 by Market Wire   Print publication without navigation


EVANSTON, Ill.--([ BUSINESS WIRE ])--Northfield Laboratories Inc. (Nasdaq: NFLD) will host its second quarter 2009 earnings conference call with the financial community on Monday, January 12, 2009 at 11:00 a.m. Eastern Time (10 a.m. Central Time).

This call is being webcast by Thomson Reuters and can be accessed at Northfield's Web site at [ http://www.northfieldlabs.com ]. A replay will be available in the same location for two weeks following the call.

The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at [ http://www.fulldisclosure.com ], Thomson Reuters individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents ([ http://www.streetevents.com ]).

Investors may also dial 866.783.2139 and enter the passcode 97752406. A replay of the call will be available for two weeks by dialing 888.286.8010 and entering the passcode 34016526.

About Northfield Laboratories

Northfield Laboratories is a leader in developing a hemoglobin-based oxygen-carrying red blood cell substitute. The initial indication we are seeking for our investigational product PolyHeme is the treatment of life-threatening red blood cell loss when an oxygen-carrying fluid is required and red blood cells are not available. PolyHeme is a solution of chemically modified human hemoglobin that requires no cross-matching and is therefore compatible with all blood types. It has an extended shelf life in excess of 12 months. For further information, visit [ http://www.northfieldlabs.com ].


Publication Contributing Sources